MARKET

IART

IART

Integra Lifesciences Hldgs Cp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

59.79
-2.54
-4.08%
After Hours: 59.79 0 0.00% 16:06 05/18 EDT
OPEN
61.89
PREV CLOSE
62.33
HIGH
61.89
LOW
59.42
VOLUME
336.66K
TURNOVER
1.84M
52 WEEK HIGH
76.70
52 WEEK LOW
55.16
MARKET CAP
4.97B
P/E (TTM)
32.56
1D
5D
1M
3M
1Y
5Y
Citigroup Adjusts Price Target on Integra LifeSciences Holdings to $67 From $70, Maintains Neutral Rating
MT Newswires · 1d ago
Integra LifeSciences Holdings (NASDAQ:IART) Has More To Do To Multiply In Value Going Forward
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Simply Wall St. · 2d ago
HILCO REDEVELOPMENT PARTNERS ANNOUNCES INTEGRA TO OCCUPY NEW BRAINTREE FACILITY
Hilco Redevelopment Partners (HRP) announced that Integra LifeSciences, NASDAQ: IART (https://www.integralife.com/home), a leading global medical technology company, will occupy approximately 100,000 square feet of HRP's newly redeveloped state-of-the-art ...
PR Newswire · 05/11 12:00
Integra (IART) Q1 Earnings Top Estimates, Margins Expand
Integra's (IART) updated 2022 financial guidance calls for strong year-over-year organic growth.
Zacks · 05/02 12:37
Are Investors Undervaluing Integra LifeSciences Holdings Corporation (NASDAQ:IART) By 39%?
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Integra LifeSciences...
Simply Wall St. · 05/01 14:12
Looking Into Integra Lifesciences's Return On Capital Employed
According to Benzinga Pro, during Q1, Integra Lifesciences (NASDAQ:IART) earned $32.90 million, a 27.51% increase from the preceding quarter. Integra Lifesciences's sales decreased to $376.64 million, a 7.12% change since Q4.
Benzinga · 04/29 13:53
IART vs. EW: Which Stock Is the Better Value Option?
IART vs. EW: Which Stock Is the Better Value Option?
Zacks · 04/28 15:40
--Oppenheimer Adjusts Integra LifeSciences Holdings Price Target to $78 From $80, Maintains Outperform Rating
MT Newswires · 04/28 11:33
More
No Data
Learn about the latest financial forecast of IART. Analyze the recent business situations of Integra Lifesciences Hldgs Cp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 12 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

16.67%Strong Buy
8.33%Buy
58.33%Hold
16.67%Under-perform
0.00%Sell
Analyst Price Target
The average IART stock price target is 73.00 with a high estimate of 85.00 and a low estimate of 65.00.
High85.00
Average73.00
Low65.00
Current 59.79
EPS
Actual
Estimate
0.210.430.640.86
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 418
Institutional Holdings: 81.43M
% Owned: 97.95%
Shares Outstanding: 83.14M
TypeInstitutionsShares
Increased
96
2.12M
New
40
793.11K
Decreased
90
1.84M
Sold Out
24
817.04K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-2.72%
Healthcare Equipment & Supplies
-2.33%
Key Executives
Non-Executive Chairman/Independent Director
Stuart Essig
President/Chief Executive Officer/Director
Jan De Witte
Chief Financial Officer/Executive Vice President
Carrie Anderson
Chief Operating Officer/Executive Vice President
Glenn Coleman
Chief Human Resource Officer/Executive Vice President
Lisa Evoli
Executive Vice President/Secretary
Eric Schwartz
Executive Vice President
Robert Davis
Executive Vice President
Michael Mcbreen
Senior Vice President/Chief Accounting Officer
Jeffrey Mosebrook
Lead Director/Independent Director
Barbara Hill
Independent Director
Rhonda Ballintyn
Independent Director
Keith Bradley
Independent Director
Shaundra Clay
Independent Director
Donald Morel
Independent Director
Raymond Murphy
Independent Director
Christian Schade
No Data
No Data
About IART
Integra LifeSciences Holdings Corporation provides regenerative technologies and neurosurgical solutions. The Company offers a portfolio of brands including AmnioExcel, Bactiseal, Certas, Codman, CUSA, DuraGen, DuraSeal, ICP Express, Integra, MediHoney, MicroFrance, PriMatrix, SurgiMend, TCC-EZ, and VersaTru. The Company offers solutions in orthopedics, neurosurgery, and reconstructive and general surgery. The Company operates through two segments: Codman Specialty Surgical segment, and Orthopedics and Tissue Technologies segment. The Codman Specialty Surgical segment includes the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care. The Orthopedics and Tissue Technologies segment includes such offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair products.

Webull offers kinds of Integra Lifesciences Holdings Corp stock information, including NASDAQ:IART real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IART stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IART stock methods without spending real money on the virtual paper trading platform.